Professional Documents
Culture Documents
Infections
MAJ Mark Burnett
Pediatric ID Fellow
MAR 2003
Neonatal Herpes
Background
A Case Study
Types of Infections
Risks of Infection
Diagnostics
Treatment
Summary
Herpes Infections
Herpes from the HHV1 HSV1
Greek to creep, HHV2 HSV2
crawl HHV3 VZV
Herpetic eruptions HHV4 EBV
described as early
as 100 AD HHV5 CMV
1960s HSV1 and HHV6 Causes?
HSV2 differentiated HHV7
HHV8 -
A Case Study A.B.
Term infant born to a 22 y/o GBS+ mother
with no Pmhx of HSV-2
4 doses of IV PCN given PTD
ROM <18 hours PTD, no maternal fevers
Forceps delivery
APGARS of 9/9
Well until fever to 101.7 at 30 hrs of life
Fever work-up initiated
A.B.
WBC 23K (50S 2B 38L)
AST 98 ALT 92
CSF 48 WBC 2650 RBC Pro 93/Glu 53
HSV PCR, Enteroviral PCR, HSV Surface cx
sent
Exam unremarkable
Amp/Gent/Acyclovir initiated
Fevers persisted over next 13 hours, again
spiking to 101.5
AST 147 / ALT 93 two days later
A.B. additional info
No history of HSV reported in mother,
father
Mother without febrile illness
Niece with a cold sore visited prior to
delivery, and held the baby after he
was born
LP repeated two days after initial study
with normalization of cell count
A New Development
Questions?
What diagnostic tests could we perform, and
how reliable are they really?
Would it be worthwhile to run tests on mom?
Is the nieces cold sore a red herring
what are the risks?
Bottom line how worried should we be
about HSV, and how would we treat it?
Neonatal HSV
1 in 2,500-5,000 deliveries / 500-1500 per yr.
Birth to 7 weeks of life
HSV2 = 70-75%, HSV1 = 25-30%
3 Main Types
Skin, Eye, Mouth (SEM)
CNS
Disseminated Disease (DISSEM)
At Risk: Premature, ROM >6hr, Fetal scalp
monitoring
Can be acquired congenitally, during the birth
process, and in the post-partum period
Routes of Transmission
85% via infected
maternal genital
tract
Ascending infection?
En route
10% postpartum
5% (or less)
intrauterine/congeni
tal infection
Congenital HSV
Rare, most Archival Photo:
devastating HSV In Utero
Healed by Time
Only 50 cases Of Birth With
Microcephally
described
Skin vesicles
Chorioretinitis
Microcephaly
Micro-ophthalmia
IUGR
Skin, Eye, Mouth (SEM)
Approximately of all
HSV infections
1st-2nd week Groin Vesicles
presentation 16 Days of Life
HSV-1, This Infant
Limited to skin, eye, Had a Cardiac Cath
(Groin Line)
mouth/mucous At 3 Days of Life
membranes
60-70% of untreated
patients progress to
CNS/disseminated
disease
SEM (cont)
Long term
neurologic sequelae
seen in 30% of
cases even if
treated
Ophthalmology
involvement
Presenting Part (SEM)
Scalp Lesions
11 Days of Life
HSV-2, Monitored
With Scalp Lead
HSV - CNS Disease
Encephalitis without
visceral involvement,
mainly involving the
temporal lobes
Early to 3rd week of life
presentation
Skin lesions may appear
late, if at all
35% of all cases, only HSV 2, Necrotic Brain
HSV Cx positive in
1-2 days (cytopathic
effect)
DFA
sensitivity/specificity
in the 75%-85%
range
PCR Testing
Detects minute
amounts of DNA, RNA
DISSEM 93%
CNS 76%
SEM 24%
False negative may
occur if CSF is obtained
too early
Order through IVF!
Diagnostics (cont)
Surface cultures
Mouth (40-50%)
Eyes (25%)
Rectum
Skin
Cultures
Stool
Urine
CSF >100 WBC/Inc. Pro
Tzanck neither
sensitive nor specific
Treatment - Acyclovir
SEM infections
60mg/kg/day divided q8h for 14 days
May be lengthened to 21 days in the near
future
Oral Acyclovir needed later in life?
DISSEM and CNS HSV infections
60mg/kg/day divided q8h for 21 days
Re-tap if CNS disease exists prior to d/c
Watch for neutropenia 2x week ANCs
Questions / Controversies
Would maternal
pre-treatment
change the time
/clinical presentation
of HSV?
Should an infant
delivered vaginally
to a mother with
active lesions be
treated?
Can HSV be
resistant to
Acyclovir?
Take Home Messages
Most neonates with HSV
infection are born to
mothers with
asymptomatic genital
shedding at delivery,
with no history of
genital herpetic lesions
No one test is 100%
sensitive / specific
Keep HSV in mind